Clotless SS Ingredients and Usage

The active ingredient is Streptokinase, a bacterial protein that activates plasminogen. The 60mg powder requires reconstitution and administration as intravenous infusion over 30-60 minutes.

Clotless SS is clinically indicated for:

• Acute myocardial infarction within 12 hours of onset
• Massive pulmonary embolism with hemodynamic instability
• Deep vein thrombosis in selected cases
• Arterial thrombosis and embolism

How Does Clotless SS Work?

Clotless SS provides thrombolysis through plasminogen activation:

1. Plasminogen Activation: Forms complex with plasminogen to create plasmin
2. Fibrin Degradation: Plasmin breaks down fibrin clots into soluble fragments
3. Clot Dissolution: Rapidly dissolves thrombi in coronary arteries
4. Systemic Effect: Causes systemic fibrinogenolysis and anticoagulation

Clotless SS Side Effects and Warnings

Common side effects include bleeding complications, allergic reactions, hypotension, and arrhythmias. Most reactions require immediate medical attention.

Serious Considerations

1. Bleeding Risk: Major hemorrhage including intracranial bleeding
2. Hypersensitivity Reactions: Anaphylaxis and serum sickness possible
3. Reperfusion Arrhythmias: Ventricular arrhythmias during coronary reperfusion
4. Re-administration Risk: Neutralizing antibodies develop after first use
5. Contraindications: Active bleeding, recent surgery, or stroke history

Clotless SS Storage Conditions

Clotless SS Injection requires strict storage protocols:

• Store refrigerated between 2°C and 8°C
• Protect from light and freezing
• Use reconstituted solution immediately
• Discard if solution appears discolored or contains particles
• Follow emergency drug handling guidelines